CORD-19:0329e0f2e3b8ab0eabe2afe0e5214cc88c61080e / 24488-24805 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T133","span":{"begin":0,"end":317},"obj":"Sentence"},{"id":"T63322","span":{"begin":0,"end":317},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In addition, combination therapy of favipiravir with the other existing therapies is also an option and favipiravir and oseltamivir combination therapy showed accelerated clinical recovery J o u r n a l P r e -p r o o f compared to oseltamivir monotherapy in severe influenza in China (Cao, 2018; Wang et al., 2019) ."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T133","span":{"begin":0,"end":317},"obj":"Sentence"}],"text":"In addition, combination therapy of favipiravir with the other existing therapies is also an option and favipiravir and oseltamivir combination therapy showed accelerated clinical recovery J o u r n a l P r e -p r o o f compared to oseltamivir monotherapy in severe influenza in China (Cao, 2018; Wang et al., 2019) ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T223","span":{"begin":266,"end":275},"obj":"Disease"}],"attributes":[{"id":"A223","pred":"mondo_id","subj":"T223","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"In addition, combination therapy of favipiravir with the other existing therapies is also an option and favipiravir and oseltamivir combination therapy showed accelerated clinical recovery J o u r n a l P r e -p r o o f compared to oseltamivir monotherapy in severe influenza in China (Cao, 2018; Wang et al., 2019) ."}